8-K Announcements
6Material company update
Mar 23, 2026·SEC
Material company update
Mar 17, 2026·SEC
Material company update
Mar 6, 2026·SEC
Cencora, Inc.(COR)Earnings, Financials & Key Ratios
COR•NYSE
$305.90
$59.5B mkt cap·38.4× P/E·Price updated May 6, 2026
AboutCencora, Inc. sources and distributes pharmaceutical products. Its U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers. The company also provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; and pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets. In addition, this segment distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and provides other services primarily to physicians who specialize in various disease states, primarily oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. The company's International Healthcare Solutions segment offers international pharmaceutical wholesale and related service, and global commercialization services; and distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers and hospitals primarily in Europe. This segment also provides specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.Show more
- Revenue$321.33B+9.3%
- EBITDA$4.71B+13.3%
- Net Income$1.55B+3.0%
- EPS (Diluted)7.96+5.7%
- Gross Margin3.16%+6.6%
- EBITDA Margin1.46%+3.7%
- Operating Margin1.14%+9.8%
- Net Margin0.48%-5.8%
- ROE122.67%-40.9%
- ROIC77.13%-17.1%
- Debt/Equity4.38-21.4%
- Interest Coverage8.69-28.9%
COR Key Insights
Cencora, Inc. (COR) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Excellent 3Y average ROE of 267.9%
- ✓24 consecutive years of dividend growth
- ✓High quality earnings: Operating CF exceeds net income
- ✓Strong 5Y sales CAGR of 11.1%
- ✓Share count reduced 2.5% through buybacks
- ✓Efficient asset utilization: 4.2x turnover
✗Weaknesses
- ✗High debt to equity ratio of 4.4x
- ✗Thin 5Y average net margin of 0.6%
- ✗Expensive at 34.2x book value
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
COR Price & Volume
Cencora, Inc. (COR) stock price & volume — 10-year historical chart
Loading chart...
COR Growth Metrics
Cencora, Inc. (COR) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years8.98%
5 Years11.09%
3 Years10.43%
TTM7.45%
Profit CAGR
10 Years-
5 Years-
3 Years-2.92%
TTM16.4%
EPS CAGR
10 Years-
5 Years-
3 Years-0.33%
TTM18.4%
Return on Capital
10 Years20.99%
5 Years20.69%
3 Years21.41%
Last Year23.09%
COR Recent Earnings
Cencora, Inc. (COR) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 11/12 qtrs (100%)●Beat Revenue 8/12 qtrs (73%)
Q1 2026Latest
Feb 4, 2026EPS
$4.08
Est $4.05
+0.7%
Revenue
$85.9B
Est $86.1B
-0.1%
Q4 2025
Nov 5, 2025EPS
$3.84
Est $3.79
+1.3%
Revenue
$83.7B
Est $83.5B
+0.3%
Q3 2025
Aug 6, 2025EPS
$4.00
Est $3.85
+3.9%
Revenue
$80.7B
Est $80.1B
+0.7%
Q2 2025
May 7, 2025EPS
$4.42
Est $4.11
+7.5%
Revenue
$75.5B
Est $75.7B
-0.3%
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q1 2026Latest | Feb 4, 2026 | $4.08vs $4.05+0.7% | $85.9Bvs $86.1B-0.1% |
| Q4 2025 | Nov 5, 2025 | $3.84vs $3.79+1.3% | $83.7Bvs $83.5B+0.3% |
| Q3 2025 | Aug 6, 2025 | $4.00vs $3.85+3.9% | $80.7Bvs $80.1B+0.7% |
| Q2 2025 | May 7, 2025 | $4.42vs $4.11+7.5% | $75.5Bvs $75.7B-0.3% |
Based on last 12 quarters of dataView full earnings history →
COR Peer Comparison
Cencora, Inc. (COR) competitors in Drug Wholesalers and Distributors — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 MCK | 98.11B | 801.01 | 31.14 | 16.22% | 1.09% | 5.33% | ||
 CAH | 46.36B | 197.00 | 30.54 | -1.87% | 0.62% | 3.99% | ||
 OMI | 171.11M | 2.24 | -0.16 | -74.19% | -39.85% | -21.12% | ||
 HSIC | 8.53B | 74.37 | 22.74 | 4.03% | 3.02% | 8.24% | 6.71% | 0.77 |
 CVS | 102.56B | 80.69 | 58.05 | 7.85% | 0.44% | 2.35% | 7.61% | 1.24 |
 PBM | 39.82M | 6.11 | -0.78 | -43.78% | ||||
 UNH | 330.28B | 363.87 | 27.50 | 11.81% | 2.68% | 11.54% | 4.87% | 0.77 |
 CI | 72.68B | 275.66 | 12.43 | 11.26% | 2.26% | 15.08% | 11.54% | 0.75 |
Compare COR vs Peers
Cencora, Inc. (COR) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
COR Income Statement
Cencora, Inc. (COR) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Line item | Sep'17 | Sep'18 | Sep'19 | Sep'20 | Sep'21 | Sep'22 | Sep'23 | Sep'24 | Sep'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 153.14B | 167.94B | 179.59B | 189.89B | 213.99B | 238.59B | 262.17B | 293.96B | 321.33B | 325.78B |
| Revenue Growth % | 4.29% | 9.66% | 6.94% | 5.74% | 12.69% | 11.5% | 9.89% | 12.12% | 9.31% | 7.45% |
| Cost of Goods Sold | 149B | 163.83B | 175.06B | 185.1B | 207.72B | 230.99B | 254.42B | 285.26B | 311.19B | 315.09B |
| COGS % of Revenue | 97.29% | 97.55% | 97.48% | 97.48% | 97.07% | 96.81% | 97.04% | 97.04% | 96.84% | - |
| Gross Profit | 4.15B▲ 0% | 4.11B▼ 0.9% | 4.53B▲ 10.2% | 4.79B▲ 5.8% | 6.27B▲ 30.8% | 7.6B▲ 21.2% | 7.76B▲ 2.1% | 8.7B▲ 12.2% | 10.14B▲ 16.6% | 10.69B▲ 0% |
| Gross Margin % | 2.71% | 2.45% | 2.52% | 2.52% | 2.93% | 3.19% | 2.96% | 2.96% | 3.16% | 3.28% |
| Gross Profit Growth % | 9.88% | -0.86% | 10.19% | 5.78% | 30.83% | 21.24% | 2.05% | 12.18% | 16.55% | - |
| Operating Expenses | 2.13B | 2.46B | 2.66B | 2.77B | 3.59B | 4.85B | 5.31B | 5.66B | 6.49B | 6.82B |
| OpEx % of Revenue | 1.39% | 1.47% | 1.48% | 1.46% | 1.68% | 2.03% | 2.03% | 1.93% | 2.02% | - |
| Selling, General & Admin | 2.13B | 2.46B | 2.66B | 2.77B | 3.59B | 4.85B | 5.31B | 5.66B | 6.49B | 6.82B |
| SG&A % of Revenue | 1.39% | 1.47% | 1.48% | 1.46% | 1.68% | 2.03% | 2.03% | 1.93% | 2.02% | - |
| Research & Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | 2.02B▲ 0% | 1.65B▼ 18.2% | 1.87B▲ 13.1% | 2.02B▲ 8.5% | 2.68B▲ 32.1% | 2.75B▲ 2.9% | 2.45B▼ 11.1% | 3.04B▲ 24.3% | 3.65B▲ 20.0% | 3.87B▲ 0% |
| Operating Margin % | 1.32% | 0.98% | 1.04% | 1.07% | 1.25% | 1.15% | 0.93% | 1.03% | 1.14% | 1.19% |
| Operating Income Growth % | 19.93% | -18.2% | 13.06% | 8.47% | 32.13% | 2.87% | -11.09% | 24.26% | 19.98% | - |
| EBITDA | 2.44B | 2.15B | 2.36B | 2.43B | 3.18B | 3.45B | 3.42B | 4.15B | 4.71B | 4.91B |
| EBITDA Margin % | 1.59% | 1.28% | 1.31% | 1.28% | 1.49% | 1.45% | 1.3% | 1.41% | 1.46% | 1.51% |
| EBITDA Growth % | 18.05% | -11.9% | 9.51% | 3.02% | 31.08% | 8.47% | -0.89% | 21.44% | 13.35% | 18.31% |
| D&A (Non-Cash Add-back) | 422.92M | 499.64M | 488.54M | 401.62M | 505.17M | 697.94M | 972.39M | 1.11B | 1.06B | 1.04B |
| EBIT | 1.07B | 1.37B | 1.16B | -5.14B | 2.4B | 2.42B | 2.44B | 2.25B | 2.68B | 2.78B |
| Net Interest Income | -145.19M | -174.7M | -157.77M | -137.88M | -174.07M | -210.67M | -228.93M | -156.99M | -291.55M | -336.02M |
| Interest Income | 3.86M | 14.94M | 37.7M | 20.64M | 8.47M | 21.31M | 46.72M | 91.69M | 128.21M | 94.96M |
| Interest Expense | 149.04M | 189.64M | 195.47M | 158.52M | 182.54M | 231.98M | 275.65M | 248.68M | 419.75M | 430.98M |
| Other Income/Expense | -1.1B | -473.53M | -899.42M | -7.32B | -453.15M | -568.62M | -285.68M | -1.04B | -1.39B | -1.53B |
| Pretax Income | 917.89M▲ 0% | 1.18B▲ 28.3% | 967.11M▼ 17.9% | -5.29B▼ 647.4% | 2.22B▲ 142.0% | 2.18B▼ 1.7% | 2.16B▼ 1.0% | 2B▼ 7.3% | 2.26B▲ 12.7% | 2.35B▲ 0% |
| Pretax Margin % | 0.6% | 0.7% | 0.54% | -2.79% | 1.04% | 0.92% | 0.82% | 0.68% | 0.7% | 0.72% |
| Income Tax | 553.4M | -438.47M | 112.97M | -1.89B | 677.25M | 516.52M | 428.26M | 484.7M | 690.52M | 706.31M |
| Effective Tax Rate % | 60.29% | -37.24% | 11.68% | 35.78% | 30.48% | 23.66% | 19.82% | 24.19% | 30.58% | 30.1% |
| Net Income | 414.48M▲ 0% | 1.66B▲ 300.1% | 855.37M▼ 48.4% | -3.4B▼ 497.4% | 1.54B▲ 145.3% | 1.7B▲ 10.3% | 1.75B▲ 2.7% | 1.51B▼ 13.5% | 1.55B▲ 3.0% | 1.63B▲ 0% |
| Net Margin % | 0.27% | 0.99% | 0.48% | -1.79% | 0.72% | 0.71% | 0.67% | 0.51% | 0.48% | 0.5% |
| Net Income Growth % | -70.97% | 300.11% | -48.42% | -497.44% | 145.3% | 10.32% | 2.74% | -13.53% | 2.99% | 16.4% |
| Net Income (Continuing) | 364.48M | 1.62B | 854.13M | -3.4B | 1.54B | 1.67B | 1.73B | 1.52B | 1.57B | 1.64B |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 117.14M | 114.29M | 179.29M | 361.06M | 282.83M | 144.28M | 140.8M | 239.07M | 187.64M |
| EPS (Diluted) | 1.64▲ 0% | 7.53▲ 359.1% | 4.04▼ 46.3% | -16.60▼ 510.9% | 7.39▲ 144.5% | 8.04▲ 8.8% | 8.53▲ 6.1% | 7.53▼ 11.7% | 7.96▲ 5.7% | 8.32▲ 0% |
| EPS Growth % | -74.05% | 359.15% | -46.35% | -510.89% | 144.52% | 8.8% | 6.09% | -11.72% | 5.71% | 18.4% |
| EPS (Basic) | 1.67 | 7.61 | 4.07 | -16.60 | 7.48 | 8.15 | 8.62 | 7.60 | 8.02 | - |
| Diluted Shares Outstanding | 221.6M | 220.34M | 211.84M | 204.78M | 208.47M | 211.21M | 204.59M | 200.28M | 195.21M | 195.32M |
| Basic Shares Outstanding | 218.38M | 217.87M | 210.16M | 204.78M | 205.92M | 208.47M | 204.59M | 198.5M | 193.82M | 194.22M |
| Dividend Payout Ratio | 77.27% | 20.08% | 39.63% | - | 23.81% | 23.06% | 22.85% | 27.58% | 28.12% | - |
COR Balance Sheet
Cencora, Inc. (COR) balance sheet — assets, liabilities & shareholders' equity
| Line item | Sep'17 | Sep'18 | Sep'19 | Sep'20 | Sep'21 | Sep'22 | Sep'23 | Sep'24 | Sep'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 24.3B | 25.89B | 28.13B | 33.02B | 38.8B | 39.59B | 42.8B | 47.72B | 52.24B | 54.15B |
| Cash & Short-Term Investments | 2.42B | 2.49B | 3.37B | 4.6B | 2.55B | 3.39B | 2.59B | 3.13B | 4.36B | 1.75B |
| Cash Only | 2.42B | 2.49B | 3.37B | 4.6B | 2.55B | 3.39B | 2.59B | 3.13B | 4.36B | 1.75B |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 10.3B | 11.31B | 12.39B | 14.3B | 18.39B | 18.45B | 20.91B | 23.87B | 25.23B | 25.98B |
| Days Sales Outstanding | 24.56 | 24.59 | 25.18 | 27.48 | 31.37 | 28.23 | 29.11 | 29.64 | 28.65 | 27.86 |
| Inventory | 11.46B | 11.92B | 11.06B | 12.59B | 15.37B | 15.56B | 17.45B | 19B | 20.49B | 24.08B |
| Days Inventory Outstanding | 28.08 | 26.55 | 23.06 | 24.82 | 27 | 24.58 | 25.04 | 24.31 | 24.04 | 24.23 |
| Other Current Assets | 118.56M | 169.12M | 1.31B | 1.53B | 2.13B | 1.53B | 1.84B | 1.71B | 2.17B | 2.34B |
| Total Non-Current Assets | 11.01B | 11.78B | 11.04B | 10.93B | 18.54B | 16.97B | 19.76B | 19.38B | 24.35B | 24.21B |
| Property, Plant & Equipment | 1.8B | 1.89B | 1.77B | 1.48B | 2.16B | 2.14B | 2.14B | 2.18B | 2.54B | 2.45B |
| Fixed Asset Turnover | 85.18x | 88.74x | 101.43x | 127.89x | 98.93x | 111.75x | 122.79x | 134.76x | 126.56x | 134.01x |
| Goodwill | 6.04B | 6.66B | 6.71B | 6.71B | 9.03B | 8.5B | 9.57B | 9.32B | 13.68B | 13.73B |
| Intangible Assets | 2.83B | 2.95B | 2.29B | 1.89B | 5.26B | 4.33B | 4.43B | 4B | 3.77B | 3.68B |
| Long-Term Investments | 57.6M | 0 | -1.86B | 0 | 0 | 60.37M | 63.12M | 66.64M | 0 | 68.21M |
| Other Non-Current Assets | -2.21B | 270.94M | 269.07M | 779.85M | 1.79B | 1.7B | 3.36B | 3.57B | 4.15B | 16.62B |
| Total Assets | 35.32B▲ 0% | 37.67B▲ 6.7% | 39.17B▲ 4.0% | 44.27B▲ 13.0% | 57.34B▲ 29.5% | 56.56B▼ 1.4% | 62.56B▲ 10.6% | 67.1B▲ 7.3% | 76.59B▲ 14.1% | 78.36B▲ 0% |
| Asset Turnover | 4.34x | 4.46x | 4.58x | 4.29x | 3.73x | 4.22x | 4.19x | 4.38x | 4.20x | 4.34x |
| Asset Growth % | 5.14% | 6.66% | 3.99% | 13.03% | 29.5% | -1.36% | 10.6% | 7.26% | 14.14% | 49.85% |
| Total Current Liabilities | 26.77B | 27.87B | 29.58B | 33.85B | 41.36B | 43.48B | 48.83B | 54.28B | 57.82B | 59.13B |
| Accounts Payable | 25.4B | 26.84B | 28.39B | 31.71B | 38.01B | 40.19B | 45.84B | 50.94B | 54.72B | 56.06B |
| Days Payables Outstanding | 62.23 | 59.79 | 59.18 | 62.52 | 66.79 | 63.51 | 65.76 | 65.18 | 64.18 | 61.38 |
| Short-Term Debt | 12.12M | 151.66M | 139.01M | 501.26M | 300.21M | 1.07B | 641.34M | 576.33M | 117.78M | 342.28M |
| Deferred Revenue (Current) | -12.12M | 1.83B | 0 | 0 | 2.86B | 0 | 310.68M | 0 | 0 | 0 |
| Other Current Liabilities | 1.36B | -948.25M | 1.06B | 1.65B | 192.07M | 2.21B | 2.04B | 2.76B | 2.98B | 2.73B |
| Current Ratio | 0.91x | 0.93x | 0.95x | 0.98x | 0.94x | 0.91x | 0.88x | 0.88x | 0.90x | 0.90x |
| Quick Ratio | 0.48x | 0.50x | 0.58x | 0.60x | 0.57x | 0.55x | 0.52x | 0.53x | 0.55x | 0.55x |
| Cash Conversion Cycle | -9.6 | -8.65 | -10.95 | -10.21 | -8.42 | -10.7 | -11.6 | -11.23 | -11.49 | -9.28 |
| Total Non-Current Liabilities | 6.43B | 6.75B | 6.6B | 10.93B | 15.39B | 13.01B | 13.21B | 12.18B | 17.02B | 17.13B |
| Long-Term Debt | 3.43B | 4.16B | 4.03B | 3.62B | 6.38B | 4.63B | 4.15B | 3.81B | 7.54B | 7.58B |
| Capital Lease Obligations | 351.63M | 0 | 0 | 385.51M | 946.15M | 864.29M | 924.25M | 1.03B | 1.42B | 1.42B |
| Deferred Tax Liabilities | 2.49B | 1.83B | 1.86B | 686.49M | 1.69B | 1.62B | 1.66B | 1.64B | 1.62B | 6.49B |
| Other Non-Current Liabilities | 2.65B | 462.65M | 419.33M | 7.14B | 6.38B | 5.89B | 6.33B | 5.55B | 6.44B | 30.47B |
| Total Liabilities | 33.2B | 34.62B | 36.18B | 45.29B | 56.75B | 56.49B | 62.04B | 66.46B | 75.08B | 76.27B |
| Total Debt | 3.43B | 4.31B | 4.17B | 4.12B | 6.68B | 5.7B | 4.79B | 4.39B | 7.66B | 7.92B |
| Net Debt | 1.01B | 1.82B | 798.7M | -478.23M | 4.14B | 2.31B | 2.2B | 1.26B | 3.3B | 6.17B |
| Debt / Equity | 1.62x | 1.41x | 1.39x | - | 11.44x | 80.01x | 7.19x | 5.58x | 4.38x | 4.38x |
| Debt / EBITDA | 1.41x | 2.00x | 1.77x | 1.70x | 2.10x | 1.65x | 1.40x | 1.06x | 1.63x | 1.61x |
| Net Debt / EBITDA | 0.41x | 0.85x | 0.34x | -0.20x | 1.30x | 0.67x | 0.64x | 0.30x | 0.70x | 0.70x |
| Interest Coverage | 13.54x | 8.71x | 9.55x | 12.77x | 14.65x | 11.86x | 8.88x | 12.22x | 8.69x | 6.44x |
| Total Equity | 2.11B▲ 0% | 3.05B▲ 44.2% | 2.99B▼ 1.9% | -660.35M▼ 122.1% | 584.41M▲ 188.5% | 71.27M▼ 87.8% | 666.29M▲ 834.8% | 786.74M▲ 18.1% | 1.75B▲ 122.1% | 2.1B▲ 0% |
| Equity Growth % | -0.7% | 44.24% | -1.86% | -122.06% | 188.5% | -87.8% | 834.84% | 18.08% | 122.07% | 705.75% |
| Book Value per Share | 9.54 | 13.84 | 14.13 | -3.22 | 2.80 | 0.34 | 3.26 | 3.93 | 8.95 | 10.73 |
| Total Shareholders' Equity | 2.11B | 2.93B | 2.99B | -839.64M | 223.35M | -289.78M | 522M | 645.94M | 1.51B | 1.91B |
| Common Stock | 2.81M | 2.84M | 2.85M | 2.88M | 2.91M | 2.93M | 2.95M | 2.96M | 2.97M | 2.98M |
| Retained Earnings | 2.4B | 3.72B | 4.24B | 518.34M | 1.67B | 2.98B | 4.32B | 5.42B | 6.53B | 6.97B |
| Treasury Stock | -4.76B | -5.43B | -6.1B | -6.51B | -6.47B | -7.02B | -8.25B | -9.82B | -10.33B | -10.43B |
| Accumulated OCI | -95.85M | -79.25M | -111.97M | -108.83M | -445.44M | -1.83B | -1.4B | -989.12M | -901.38M | -905.08M |
| Minority Interest | 0 | 117.14M | 114.29M | 179.29M | 361.06M | 282.83M | 144.28M | 140.8M | 239.07M | 187.64M |
COR Cash Flow Statement
Cencora, Inc. (COR) cash flow — operating, investing & free cash flow history
| Line item | Sep'17 | Sep'18 | Sep'19 | Sep'20 | Sep'21 | Sep'22 | Sep'23 | Sep'24 | Sep'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | 1.49B | 1.41B | 2.34B | 2.21B | 2.67B | 2.7B | 3.91B | 3.48B | 3.88B | 3.88B |
| Operating CF Margin % | 0.97% | 0.84% | 1.31% | 1.16% | 1.25% | 1.13% | 1.49% | 1.19% | 1.21% | - |
| Operating CF Growth % | -53.15% | -5.21% | 66.08% | -5.84% | 20.82% | 1.37% | 44.7% | -10.91% | 11.2% | 614.34% |
| Net Income | 414.48M | 1.62B | 854.13M | -3.4B | 1.54B | 1.67B | 1.75B | 1.52B | 1.57B | 1.63B |
| Depreciation & Amortization | 432.33M | 510.11M | 497.51M | 408.01M | 514.79M | 709.84M | 980.85M | 448.2M | 0 | 761.01M |
| Stock-Based Compensation | 62.21M | 62.32M | 58.87M | 74.41M | 99.59M | 93.4M | 124.62M | 148M | 0 | 117.69M |
| Deferred Taxes | 319.07M | -795.52M | 28.54M | -1.54B | 334.87M | 196.18M | -118.86M | -102.32M | 0 | 23.91M |
| Other Non-Cash Items | -141.1M | 189.31M | 541.59M | 4.75M | -194.59M | 176.79M | 304.89M | 1.17B | 2.27B | 1.51B |
| Working Capital Changes | 402.02M | -170.72M | 363.38M | 6.66B | 367.32M | -139.66M | 874.54M | 298.69M | 35.42M | 238.82M |
| Change in Receivables | -1.28B | -657.77M | -1.24B | -1.63B | -930.08M | -1.66B | -2.71B | -2.78B | -1.92B | -1.78B |
| Change in Inventory | -431.45M | -4.92M | -167.99M | -1.62B | -1.12B | -665.37M | -2.18B | -1.48B | -1.27B | -3.13B |
| Change in Payables | 1.47B | 859.04M | 1.56B | 3.3B | 2.05B | 3.32B | 6.1B | 4.97B | 3.69B | 5.66B |
| Cash from Investing | -498.04M | -1.11B | -375.83M | -379.87M | -6.14B | -368.44M | -2.6B | -618.1M | -4.98B | -4.93B |
| Capital Expenditures | -466.4M | -336.41M | -310.22M | -369.68M | -438.22M | -496.32M | -458.36M | -487.17M | -667.98M | -681.46M |
| CapEx % of Revenue | 0.3% | 0.2% | 0.17% | 0.19% | 0.2% | 0.21% | 0.17% | 0.17% | 0.21% | - |
| Acquisitions | -61.65M | -785.3M | -63.95M | -56.08M | -5.73B | 120.28M | 0 | 0 | 0 | -91.41M |
| Investments | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 52.5M | 10.6M | -1.66M | -267.71M | 22.3M | 7.6M | -2.14B | -130.92M | -4.31B | -4.16B |
| Cash from Financing | -1.31B | -242.87M | -1.09B | -603.62M | 1.95B | -1.75B | -2.22B | -2.33B | 2.25B | -916.83M |
| Debt Issued (Net) | -749.55M | 635.7M | -133.07M | -32.01M | 2.22B | -923.1M | -623.26M | -385.45M | 3.2B | -326.36M |
| Equity Issued (Net) | -1000K | -1000K | -1000K | -1000K | 1000K | -1000K | -1000K | -1000K | -1000K | 2M |
| Dividends Paid | -320.27M | -333.04M | -338.97M | -343.58M | -366.65M | -391.69M | -398.75M | -416.17M | -437.08M | -452.71M |
| Share Repurchases | -329.93M | -639.24M | -674.03M | -420.45M | -82.15M | -483.7M | -1.18B | -1.49B | -435.47M | -50M |
| Other Financing | -15.98M | -44.75M | -16.67M | -33.47M | -13.65M | -48.2M | -80.69M | -75.85M | -103.14M | -116.39M |
| Net Change in Cash | -321.85M▲ 0% | 57.4M▲ 117.8% | 881.68M▲ 1436.0% | 1.22B▲ 38.8% | -1.53B▼ 224.9% | 523.41M▲ 134.3% | -840.65M▼ 260.6% | 544.99M▲ 164.8% | 1.1B▲ 101.2% | -1.62B▲ 0% |
| Free Cash Flow | 1.02B▲ 0% | 1.07B▲ 5.1% | 2.03B▲ 89.2% | 1.84B▼ 9.7% | 2.23B▲ 21.3% | 2.21B▼ 1.0% | 3.45B▲ 56.5% | 3B▼ 13.2% | 3.21B▲ 7.0% | 3.61B▲ 0% |
| FCF Margin % | 0.67% | 0.64% | 1.13% | 0.97% | 1.04% | 0.92% | 1.32% | 1.02% | 1% | 1.11% |
| FCF Growth % | -62.32% | 5.12% | 89.19% | -9.66% | 21.28% | -0.97% | 56.47% | -13.19% | 6.99% | 665.31% |
| FCF per Share | 4.61 | 4.88 | 9.60 | 8.97 | 10.69 | 10.45 | 16.88 | 14.97 | 16.43 | 16.43 |
| FCF Conversion (FCF/Net Income) | 3.59x | 0.85x | 2.74x | -0.65x | 1.73x | 1.59x | 2.24x | 2.31x | 2.49x | 2.22x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
COR Key Ratios
Cencora, Inc. (COR) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | 19.53% | 64.22% | 28.31% | -291.45% | 263.5% | 518.18% | 473.26% | 207.72% | 122.67% | 77.54% |
| Return on Invested Capital (ROIC) | 43.29% | 30.99% | 32.33% | 114.45% | 112% | 58.08% | 69.93% | 92.99% | 77.13% | 77.13% |
| Gross Margin | 2.71% | 2.45% | 2.52% | 2.52% | 2.93% | 3.19% | 2.96% | 2.96% | 3.16% | 3.28% |
| Net Margin | 0.27% | 0.99% | 0.48% | -1.79% | 0.72% | 0.71% | 0.67% | 0.51% | 0.48% | 0.5% |
| Debt / Equity | 1.62x | 1.41x | 1.39x | - | 11.44x | 80.01x | 7.19x | 5.58x | 4.38x | 4.38x |
| Interest Coverage | 13.54x | 8.71x | 9.55x | 12.77x | 14.65x | 11.86x | 8.88x | 12.22x | 8.69x | 6.44x |
| FCF Conversion | 3.59x | 0.85x | 2.74x | -0.65x | 1.73x | 1.59x | 2.24x | 2.31x | 2.49x | 2.22x |
| Revenue Growth | 4.29% | 9.66% | 6.94% | 5.74% | 12.69% | 11.5% | 9.89% | 12.12% | 9.31% | 7.45% |
COR SEC Filings & Documents
Cencora, Inc. (COR) SEC filings — annual & quarterly reports (10-K, 10-Q)
COR Frequently Asked Questions
Cencora, Inc. (COR) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Cencora, Inc. (COR) reported $325.78B in revenue for fiscal year 2025. This represents a 5768% increase from $5.55B in 1996.
Cencora, Inc. (COR) grew revenue by 9.3% over the past year. This is steady growth.
Yes, Cencora, Inc. (COR) is profitable, generating $1.63B in net income for fiscal year 2025 (0.5% net margin).
Dividend & Returns
Yes, Cencora, Inc. (COR) pays a dividend with a yield of 0.73%. This makes it attractive for income-focused investors.
Cencora, Inc. (COR) has a return on equity (ROE) of 122.7%. This is excellent, indicating efficient use of shareholder capital.
Cencora, Inc. (COR) generated $3.61B in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.
Explore More COR
Cencora, Inc. (COR) financial analysis — history, returns, DCA and operating performance tools
Full COR Stock Analysis
Analyst verdict, bull/bear case, risk factors and peer comparison
Total Return Calculator
Historical returns with dividends reinvested
DCA Calculator
Dollar cost averaging vs lump sum
Dividend History
Yield, growth, payout safety & DRIP
Earnings History
EPS trends, net income & profitability
Price History
Long-term charts & historical price data
Revenue History
Sales growth patterns & revenue breakdown
Financial Ratios
30 years of market, efficiency and balance-sheet ratios
Valuation
DCF intrinsic value, peer multiples & estimates